These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 3881881

  • 1. Involvement of endogenous prostaglandins in salt-induced hypertension.
    Ogihara T, Gotoh S, Tabuchi Y, Kumahara Y.
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):114-8. PubMed ID: 3881881
    [Abstract] [Full Text] [Related]

  • 2. PGE2, 6-O-PGF1 alpha and sodium balance in essential hypertensive patients.
    Gotoh S, Ogihara T, Tabuchi Y, Kumahara Y.
    Prostaglandins Leukot Med; 1984 Sep; 15(3):293-301. PubMed ID: 6387719
    [Abstract] [Full Text] [Related]

  • 3. Effects of intravenous administration of a calcium antagonist on prostaglandins and thromboxane in plasma and urine in humans.
    Honda M, Manabe R, Minato M, Watanabe M, Fukuda N, Izumi Y, Hatano M.
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):289-302. PubMed ID: 3532135
    [Abstract] [Full Text] [Related]

  • 4. Sodium chloride as regulator of renal prostaglandin E2 production in patients with essential hypertension.
    Stahl RA, Jonassen AJ, Paravicini M, Schollmeyer P.
    Klin Wochenschr; 1982 Jun 01; 60(11):579-81. PubMed ID: 7050523
    [Abstract] [Full Text] [Related]

  • 5. Elimination from the circulation of cats of 6-keto-prostaglandin E1 compared with prostaglandins E2 and I2.
    Förstermann U, Neufang B.
    J Pharm Pharmacol; 1983 Nov 01; 35(11):724-8. PubMed ID: 6139453
    [Abstract] [Full Text] [Related]

  • 6. Hypotensive mechanism of potassium supplementation in salt-loaded patients with essential hypertension.
    Tabuchi Y, Ogihara T, Gotoh S, Masuo K, Hashizume K, Kumahara Y.
    J Clin Hypertens; 1985 Jun 01; 1(2):145-52. PubMed ID: 3869819
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin II-induced hypertension in the rat. Effects on the plasma concentration, renal excretion, and tissue release of prostaglandins.
    Diz DI, Baer PG, Nasjletti A.
    J Clin Invest; 1983 Aug 01; 72(2):466-77. PubMed ID: 6575977
    [Abstract] [Full Text] [Related]

  • 8. The role of urinary PGE2 and renin-angiotensin-aldosterone system in the pathogenesis of essential hypertension.
    Ruilope L, Garcia Robles R, Barrientos A, Bernis C, Alcazar J, Tresguerres JA, Mancheño E, Millet VG, Sancho J, Rodicio JL.
    Clin Exp Hypertens A; 1982 Aug 01; 4(6):989-1000. PubMed ID: 7047008
    [Abstract] [Full Text] [Related]

  • 9. Effect of chronic and acute changes in sodium balance on the urinary excretion of prostaglandins E2 and F2 alpha in patients with essential hypertension.
    Rathaus M, Korzets Z, Bernheim J.
    Nephron; 1982 Aug 01; 31(4):337-42. PubMed ID: 6960266
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol.
    Ylitalo P, Pitkäjärvi T, Pyykönen ML, Nurmi AK, Seppälä E, Vapaatalo H.
    Clin Pharmacol Ther; 1985 Oct 01; 38(4):443-9. PubMed ID: 3899459
    [Abstract] [Full Text] [Related]

  • 11. Renal vein prostaglandins in renovascular hypertensive patients.
    Tabuchi Y, Ogihara T, Kumahara Y.
    Prostaglandins Leukot Med; 1985 Sep 01; 19(3):219-26. PubMed ID: 3903775
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diminished urinary prostacyclin metabolite in essential hypertension.
    Grose JH, Lebel M, Gbeassor FM.
    Clin Sci (Lond); 1980 Dec 01; 59 Suppl 6():121s-123s. PubMed ID: 7004719
    [Abstract] [Full Text] [Related]

  • 14. Effects of cicletanine on prostaglandin I2 and E2 levels in patients with essential hypertension.
    Yasu T, Imanishi M.
    Am J Hypertens; 1997 Jul 01; 10(7 Pt 1):750-5. PubMed ID: 9234829
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hormonal pattern during development of hypertension in spontaneously hypertensive rats (SHR).
    Herlitz H, Lundin S, Henning M, Aurell M, Karlberg BE, Berglund G.
    Clin Exp Hypertens A; 1982 Jul 01; 4(6):915-35. PubMed ID: 7047004
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of PGE2, 6-keto PGF1 alpha and renin release from dog kidneys.
    Bugge JF, Vikse A, Dahl E, Slørdahl SH, Kiil F.
    Acta Physiol Scand; 1986 Jun 01; 127(2):197-205. PubMed ID: 3088915
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.